Investor Ideas #Potcasts #Cannabis News and Stocks on
the Move: Aphria (TSX: $APHA.TO) (NYSE: $APHA), Choom (CSE: $CHOO.C) ,
Aurora (TSX: $ACB.TO) (NYSE: $ACB), FSD Pharma (CSE: $HUGE.C), Khiron
(TSXV: $KHRN.V), Green Growth (CSE: $GGB.C) and Nextleaf (CSE: $OILS.C)
Delta,
Kelowna, BC –March 28, 2019 (Investorideas.com Newswire) www.Investorideas.com,
a global news source covering leading sectors including marijuana and hemp
stocks and its potcast site, www.potcasts.ca release today’s edition
of Investorideas.com potcastsCM - cannabis
news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read
this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/03281APHA-CHOO-ACB-HUGE-KHRN-GGB-OILS.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another Investorideas.com “potcast”, looking at
cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today
we are looking at announcements from Aphria Inc. (TSX:
APHA) (NYSE:
APHA), Choom Holdings Inc. (CSE:
CHOO) (OTCQB:
CHOOF), Aurora Cannabis Inc. (TSX:
ACB) (NYSE:
ACB), FSD Pharma Inc. (CSE:
HUGE) (OTCQB:
FSDDF), Khiron Life Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF), Green Growth Brands, Inc. (CSE:
GGB) (OTCQB:
GGBXF) and Nextleaf Solutions Ltd. (CSE:
OILS).
Aphria Inc. announced that
it will release financial results for the fiscal third quarter and nine months
ended February 28, 2019 on April 15, 2019 before market open.
Choom Holdings Inc., an emerging adult and medical use
cannabis company that has secured one of the largest national retail networks
in Canada, announced that
it has signed a memorandum of understanding with Better Choice Company, Inc.
for the exclusive Canadian distribution rights to Better Choice's CBD Bona Vida
brand of products targeted for animal health and wellness once approved for
sale in Canada. The terms of the MOU are not material.
According to the American Pet Products
Association, U.S. pet owners are estimated to have spent over $70 billion in
2018 on pet supplies, treatments and veterinary care. As CBD pet products become more readily
available and accepted, well positioned suppliers and distributors will be able
to exploit the tremendous opportunities for growth in the CBD pet sales.
Under its Bona Vida brand, Better Choice
offers a suite of CBD pet focused products in the form of oils and soft chews
with several formulations designed to aid the state of good health and
well-being in pets. Bona Vida has
formulations which specifically target animals Relaxation & Heart Support,
Muscle & Joint, as well as, Skin & Body.
"We are excited that Better Choice
has chosen us as their exclusive distributor in Canada for their pet focused
CBD products," states Chris Bogart, President and CEO of Choom. "We
recognize the importance of growing our brand portfolio and having the sole
distribution rights for Better Choice products helps us achieve that in an
entirely new market on the horizon in pet use products. From what we know of in the United States,
the CBD products for pet use market has proven to be a high margin business. As
the normalization of cannabis-based products in Canada grows, consumers will
begin to shift towards these new natural alternative treatments for their
pets."
Aurora Cannabis Inc. announced
today that the Company and its wholly-owned
subsidiary CanniMed Therapeutics, have added product information numbers (PINs)
to 78 medical cannabis products to better facilitate and track insurance
coverage for their Canadian patients. The products that received PINs include
dried flower, capsules, soft gels, topicals and oils.
PINs help employers and insurance
companies classify and incorporate health care products into benefit coverage
plans. Patients submitting claims to their third-party insurer can now identify
specific products and thereby speed up the adjudication and medical coverage
process. MedReleaf, another wholly-owned
subsidiary of Aurora, introduced PINs to 57 medical cannabis products in 2018.
"This is great news for insurance
companies, employers and most importantly our patients," said Aurora CEO
Terry Booth. "Introducing PINs for medical cannabis products will make the
claims process more seamless, enabling insurance companies to add these
products to their formularies while providing patients and employers with a
simplified process to complete claims. It's another step toward enhancing
patient access, something Aurora cares deeply about."
FSD Pharma Inc. announced
today the signing of a consulting agreement
with Joseph L. Romano, a well-respected lawyer with a strong track-record in
personal injury law. Mr. Romano has been working with medical cannabis since 2006,
assisting people coping with chronic pain to have access to medical cannabis, a
viable alternative to opioid based medications.
Pursuant to the terms of the agreement,
Mr. Romano will provide consulting on the inner workings of third party
actions, WSIB claim handling, first party coverage and no fault benefits across
Canada. Mr. Romano will also assist in identifying strategic acquisitions that
will enhance shareholder value.
Commenting on the agreement, Dr. Raza
Bokhari, Executive Co-Chairman and interim CEO said, "We are very excited
to engage Mr. Romano in advance of our anticipated sales license. This is a
very timely and important agreement for FSD Pharma to maximize the
opportunities in the Canadian market for our products and fits well with our strategy
of establishing the company as a leader in medical cannabis."
Khiron Life Sciences Corp., a
vertically integrated cannabis leader with core operations in Latin America, announced
today its participation, through Matt Murphy's
appointment, in the newly formed National Cannabis Roundtable
("NCR"), a campaign aimed at reforming US federal cannabis laws. The
NCR will focus on advocating for a rational legal framework for cannabis reform
in the US with former Speaker of the House, John Boehner, serving as Honorary
Chairman.
Matt Murphy, Khiron Vice President of
Compliance, who will represent the Company on the NCR, stated, "With
two-thirds of Americans indicating support for legalization of cannabis in some
form, and safety and security being central to our mission across the entire
supply chain, we believe that now is the time to work alongside our colleagues
to inform and advocate for an open market that improves lives, creates jobs and
establishes a national cannabis industry for the 21st century."
As Vice President of Compliance for
Khiron and former Chief of Pharmaceutical Investigations for the U.S. Drug
Enforcement Administration ("DEA"), Mr. Murphy is an executive leader
with broad based domestic and international expertise in both the federal and
private sectors. As a career Special Agent with the DEA for 25 years, he served
in a multitude of positions in the fields of drug law enforcement, risk
assessment and system development, regulatory compliance, and training. Mr.
Murphy directs the Company's compliance activity by implementing closed loop
systems to prevent product diversion and to enhance standard operating
procedures across Khiron's plant-to-patient value chain based on the DEA protocols
used to enforce compliance for the handling and distribution of controlled
substances in the U.S.
Green Growth Brands, Inc. announced the
opening of its newest Seventh Sense
Botanical Therapy CBD shop today at Mayfair Mall in Greater Milwaukee, a
Brookfield Properties center. This new location represents the sixth Seventh
Sense Shop to open in the United States.
"Mayfair Mall is the premier mall in
Greater Milwaukee and we look forward to bringing a remarkable CBD store
experience to new customers in the region," said Peter Horvath, CEO of
Green Growth Brands. "Physical shops are our strongest marketing assets,
and our presence in the new location will drive hundreds-of-thousands
impressions with consumers. As we gear-up to open over 100 CBD shops by
mid-summer we are pleased with early signs of conversion, repeat purchases and
building engagement with our current shops and online with
ShopSeventhSense.com."
Nextleaf Solutions Ltd. announced that
it has been issued a patent by the United States Patent and Trade Office
pertaining to the Company's proprietary process of extraction, refinement, and
distillation of cannabinoids from marijuana and hemp.
The resulting THC or CBD distillate is
tasteless, odourless, standardized for potency, and ready to use in a wide
range of products, including topicals, transdermal or sublingual delivery
technology, vape technology, edible oils, beverages, and water-soluble
extracts. Nextleaf's patented technology allows for low-quality dried cannabis
biomass to be efficiently processed into a high-purity distilled oil,
simplifying the manufacturing of differentiated cannabinoid formulations and
delivery methods.
Nextleaf further announced that it has been
issued a standard patent by IP Australia – the Australian Government agency
that administers intellectual property ("IP") rights - for the
Company's unique, industrial-scale process of producing purified cannabinoid
distillate.
The Company's management believes, to the
best of its knowledge, that Nextleaf is the first publicly traded company to be
issued a patent for the extraction and purification of cannabinoids.
"Nextleaf Solutions has succeeded in
beating big pharma, big tobacco, big alcohol, and every single billion-dollar
cannabis company to the first issued patent for the extraction and purification
of cannabinoids." said Paul Pedersen, CEO. "We believe companies that
can develop and protect valuable intellectual property will benefit substantially
in the long-term, especially in an industry as young as the cannabis industry.”
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the
Investorideas.com website
and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an
Investor ideas member , plus get weekly updates with new pot stocks added and
get the daily potcast for Investor Ideas #Potcasts #Cannabis
News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news and press releases plus
we create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto
Corner and Podcast, Play by Play sports and stock
news column, Investor
Ideas #Potcasts #Cannabis News and Stocks
on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI Eye Podcast
and column covering developments in AI.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Contact each company
directly regarding content and press release questions. Disclosure is posted
for each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers.
Learn more about
Investor ideas podcast and news publication
services and costs https://www.investorideas.com/News-Upload/
Global investors
must adhere to regulations of each country.
Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does
not condone the use of cannabis except where permissible by law. Our site does
not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment